The Annual Global Orgasm for Peace

Verastem Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Retrieved on: 
Wednesday, November 8, 2023

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the third quarter ending September 30, 2023 and highlighted recent progress.

Key Points: 
  • Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the third quarter ending September 30, 2023 and highlighted recent progress.
  • Verastem Oncology ended the third quarter of 2023 with cash, cash equivalents and investments of $165.7 million.
  • Research & development expenses for the 2023 Quarter were $13.9 million, compared to $11.3 million for the 2022 Quarter.
  • Selling, general & administrative expenses for the 2023 Quarter were $7.4 million, compared to $6.4 million for the 2022 Quarter.

Verastem Oncology Announces Efficacy and Safety Data of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) in Heavily Pretreated Patient Population

Retrieved on: 
Monday, November 6, 2023

Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today results of the efficacy and safety of avutometinib and defactinib in recurrent low-grade serous ovarian cancer (LGSOC) following prior systemic therapy.

Key Points: 
  • Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today results of the efficacy and safety of avutometinib and defactinib in recurrent low-grade serous ovarian cancer (LGSOC) following prior systemic therapy.
  • The analysis also evaluated efficacy in the context of best response to most recent prior treatment in the metastatic/recurrent setting.
  • The safety profiles of avutometinib and defactinib were similar in the less and more heavily pretreated subgroups and both analyses were consistent with previously reported safety data.
  • Dr. Grisham is a paid consultant for Verastem Oncology.

Russell Bedford celebrates 40 years at Annual Global Conference in Montreal

Retrieved on: 
Saturday, October 28, 2023

LONDON, Oct. 28, 2023 /PRNewswire-PRWeb/ -- Russell Bedford members from around the globe gathered in Montreal, Canada for a historic celebration at the 40th Annual Global Conference which took place at the Hotel William Gray, located in the heart of the Old Port of Montreal.

Key Points: 
  • Russell Bedford members from around the globe gathered in Montreal, Canada for a historic celebration at the 40th Annual Global Conference which took place at the Hotel William Gray, located in the heart of the Old Port of Montreal.
  • LONDON, Oct. 28, 2023 /PRNewswire-PRWeb/ -- Russell Bedford members from around the globe gathered in Montreal, Canada for a historic celebration at the 40th Annual Global Conference which took place at the Hotel William Gray, located in the heart of the Old Port of Montreal.
  • Speaking about the 40th Annual Global Conference, Russell Bedford Chair, Daniel Ryba said: "This has been an unforgettable conference.
  • CEO, Stephen Hamlet, added: "It has been my immense pleasure to be in Montreal to celebrate Russell Bedford's 40th Annual Global Conference.

lululemon Announces the Formation of Mental Wellbeing Global Advisory Board

Retrieved on: 
Thursday, August 3, 2023

lululemon (NASDAQ:LULU) today announced the creation of a Mental Wellbeing Global Advisory Board to help the company develop best practices and influence a global conversation to improve mental wellbeing outcomes for both employees and communities around the world.

Key Points: 
  • lululemon (NASDAQ:LULU) today announced the creation of a Mental Wellbeing Global Advisory Board to help the company develop best practices and influence a global conversation to improve mental wellbeing outcomes for both employees and communities around the world.
  • Employee Mental Wellbeing Offerings: Provide guidance on mental wellbeing offerings and support for lululemon employees.
  • “With the guidance of our expert advisors, we are excited to take our work to the next level and advance mental wellbeing outcomes throughout our global collective and beyond.”
    Members of the inaugural lululemon Mental Wellbeing Global Advisory Board span across the globe and include leaders who have been in long-term collaboration with lululemon on advancing wellbeing through lululemon’s global Ambassador program and previous partnerships such as the National Alliance for Mental Illness (NAMI).
  • The creation of the Mental Wellbeing Global Advisory Board builds upon lululemon’s work to advance and support mental wellbeing for its people and communities.

SELLAS Life Sciences Announces Abstract Accepted for Presentation at International Gynecologic Cancer Society Annual Meeting

Retrieved on: 
Thursday, June 15, 2023

NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced acceptance of an abstract for a poster presentation at the Annual Global Meeting of the International Gynecologic Cancer Society (IGCS 2023) which will be held November 5-7, 2023, in Seoul, South Korea.

Key Points: 
  • NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced acceptance of an abstract for a poster presentation at the Annual Global Meeting of the International Gynecologic Cancer Society (IGCS 2023) which will be held November 5-7, 2023, in Seoul, South Korea.
  • Presenter: Roisin E. O’Cearbhaill, M.D., Research Director, Gynecologic Medical Oncology Service; Clinical Director, Solid Tumor, Cellular Therapy Service; and Associate Attending Physician Memorial Sloan Kettering Cancer Center, New York, NY

Cervello Wins Fifth Consecutive Global InfoSec "Best Solution in Railway Cybersecurity" Award

Retrieved on: 
Thursday, April 27, 2023

TEL AVIV, Israel, April 27, 2023 /PRNewswire/ -- Cervello Ltd., the trusted cybersecurity provider for railways worldwide, has announced that it has won the Annual Global InfoSec Awards as "Best Solution in Railway Cybersecurity" for the fifth consecutive year.

Key Points: 
  • TEL AVIV, Israel, April 27, 2023 /PRNewswire/ -- Cervello Ltd., the trusted cybersecurity provider for railways worldwide, has announced that it has won the Annual Global InfoSec Awards as "Best Solution in Railway Cybersecurity" for the fifth consecutive year.
  • The highly coveted Cyber Defense Magazine's award validates Cervello 's ongoing commitment to providing purpose-built, end-to-end railway security with no impact on business continuity.
  • "We are proud to win this prestigious award in the significant area of rail cybersecurity," said Roie Onn, CEO and Co-Founder of Cervello.
  • "Securing railways is essential for the safe transport of both people and goods, as rail is the internal backbone of most national logistics systems.

Cervello Wins Fifth Consecutive Global InfoSec "Best Solution in Railway Cybersecurity" Award

Retrieved on: 
Thursday, April 27, 2023

TEL AVIV, Israel, April 27, 2023 /PRNewswire/ -- Cervello Ltd., the trusted cybersecurity provider for railways worldwide, has announced that it has won the Annual Global InfoSec Awards as "Best Solution in Railway Cybersecurity" for the fifth consecutive year.

Key Points: 
  • TEL AVIV, Israel, April 27, 2023 /PRNewswire/ -- Cervello Ltd., the trusted cybersecurity provider for railways worldwide, has announced that it has won the Annual Global InfoSec Awards as "Best Solution in Railway Cybersecurity" for the fifth consecutive year.
  • The highly coveted Cyber Defense Magazine's award validates Cervello 's ongoing commitment to providing purpose-built, end-to-end railway security with no impact on business continuity.
  • "We are proud to win this prestigious award in the significant area of rail cybersecurity," said Roie Onn, CEO and Co-Founder of Cervello.
  • "Securing railways is essential for the safe transport of both people and goods, as rail is the internal backbone of most national logistics systems.

EdgeQ Wins Multiple 2023 Global Mobile (GLOMO) Awards Including the Coveted CTO Choice Award for Outstanding Mobile Technology

Retrieved on: 
Thursday, March 9, 2023

EdgeQ Inc, a leader in 5G wireless infrastructure, won two prestigious awards at this year’s 2023 Global Mobile (GLOMO) Awards at MWC Barcelona.

Key Points: 
  • EdgeQ Inc, a leader in 5G wireless infrastructure, won two prestigious awards at this year’s 2023 Global Mobile (GLOMO) Awards at MWC Barcelona.
  • As the only semiconductor and startup company winner, EdgeQ won in the categories of “Best Digital Tech Breakthrough for Companies with Under $10 Million Annual Global Revenue” and the highly coveted “CTO Choice Award for Outstanding Mobile Technology.” The CTO Choice Award was chosen by a panel of more than 20 distinguished CTOs from every continent, selecting the overall technology winner from each of the seven best “Mobile Tech” award winners.
  • To be recognized by this sector’s most prominent and established experts as a technology innovator is a tremendous honor.
  • To learn more about how EdgeQ is pioneering the 5G infrastructure market, please visit www.edgeq.io .

Association of Professional Insurance Women (APIW) to Honor Janet Jordan-Foster as APIW 2023 Insurance Woman of the Year

Retrieved on: 
Tuesday, January 31, 2023

In announcing the award, APIW President Elizabeth Kramer said, "We are thrilled to present the 2023 APIW Woman of the Year award to Janet Jordan-Foster.

Key Points: 
  • In announcing the award, APIW President Elizabeth Kramer said, "We are thrilled to present the 2023 APIW Woman of the Year award to Janet Jordan-Foster.
  • She is an incredibly thoughtful leader and has brought balance, reason and insights into numerous important discussions meant to support and advance women and other groups.
  • We are pleased to have Janet represent APIW as this year's Woman of the Year."
  • "On behalf of AXIS, I am delighted to congratulate Janet on this recognition," said Albert Benchimol, President and CEO of AXIS.

Cervello Named "Best Solution in Railway Cybersecurity" at the 2022 Global InfoSec Awards

Retrieved on: 
Monday, June 6, 2022

TEL AVIV, Israel , June 6, 2022 /PRNewswire/ -- Cervello Ltd., the leading rail cybersecurity company, proudly announces its fourth consecutive win at the Annual Global InfoSec Awards as "Best Solution in Railway Cybersecurity". The award, granted by Cyber Defense Magazine, a leading electronic information security magazine, is a testament to Cervello's continued success in providing rail organizations with the highest level of security while still prioritizing business continuity.

Key Points: 
  • TEL AVIV, Israel, June 6, 2022 /PRNewswire/ -- Cervello Ltd., the leading rail cybersecurity company, proudly announces its fourth consecutive win at the Annual Global InfoSec Awards as "Best Solution in Railway Cybersecurity".
  • Cervello is a trusted leader in railway cybersecurity that ensures safety, reliability, and business continuity for rail organizations across the globe.
  • By deploying Cervello's patented security solution, fleets are presented with a contextual reflection of their operations while continuously monitoring their mission-critical assets.
  • Learn more at www.cyberdefenseawards.com
    Cyber Defense Magazine is the premier source of cyber security news and information for InfoSec professions in business and government.